The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Therapeutics Development Initiative, 2009Determination and Validation of the Molecular Target of J3, a Neuroprotective Lead Compound, for Its Optimization as a Disease-modifying Candidate for Parkinson's Disease
Objective/Rationale:
We have identified a small molecule, designated J3, which shows promising neuroprotection in an acute animal model of Parkinson’s disease (PD). To reach our ultimate goal of... -
Biomarkers, 2009Development of an alpha6*-Selective Neuronal Nicotinic Receptor (NNR) Imaging Agent as a Parkinson's Disease Biomarker
Objective/Rationale:
The availability of a selective PET radiotracer for the drug target is critical for determining receptor occupancy in humans. NNR subtypes containing the alpha? subunit have been... -
Biomarkers, 2009High Resolution Diffusion Tensor Imaging in Parkinson's Disease and Parkinson Plus Syndromes
Objective/Rationale:
An objective and valid trait and state biomarker of Parkinson’s disease will help therapeutic development by providing a measure to help confirm diagnosis (trait), and track... -
Rapid Response Innovation Awards, 2009Possibility of Small Molecule Activation of PINK1 Kinase Activity
Objective/Rationale:
Many genetic disorders are caused by the loss of a functional protein which protects cells from disease. These disorders are difficult to treat with drugs because most drugs block... -
MJFF Research Grant, 2009Supplemental Biomarkers Study to Clinical Trial for CoQ10
Objective/Rationale:
There is a critical need for biomarkers of Parkinson’s disease (PD), for accurate and earlier diagnosis, and for monitoring treatment effects. We are investigating two potential... -
MJFF Research Grant, 2009Assessing Heart Rate Variability (HRV) in the Parkinson's Associated Risk Study (PARS) Cohort
Objective/Rationale:
The objective of this study is to determine if HRV, which is reduced in PD, is significantly reduced in subjects with hyposmia (loss of smell) compared to subjects who are...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.